About National Nurses Week, May 6-12
The roles nurses play go beyond serving in a hospital and clinic, where they often connect patients and other medical personnel. They can also be found in research labs, in classrooms, and evaluating informatics and performing analysis. Each area of expertise contributes to advancing the mission and impact of the MHS enterprise.
Nurses are contributing to Department of Defense efforts as part of the national COVID-19 pandemic response. Protecting service members, their families and the MHS workforce is the DoD’s top priority that nurses are delivering on while caring for patients as a final line of defense against COVID-19.
Register for a free Nurses Week Course to earn CE/CMEs
You also may be interested in...
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.
Policy
This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.
Policy
This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.
Policy
This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.
Policy
This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).
Policy
This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.
Policy
This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.
- Identification #: 3020-01
- Date: 11/3/2020
- Type: Administrative Instructions
- Topics:
Coronavirus
Policy
This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.
- Identification #: DHA AI 3020.01
- Date: 6/12/2020
- Type: Administrative Instructions
- Topics:
Coronavirus
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (i):
• Provides utilization guidance and funding requirements for the RHRP contract to supplement Reserve Component Individual Medical Readiness (IMR) and Deployment Health activities when Service organic health readiness resources are not available to meet mission requirements.
• Provides utilization guidance and funding requirements for the RHRP contract for Active Duty enrolled in TRICARE Prime Remote, U.S. Coast Guard (USCG), USCG Reserves, and re-deploying DoD civilians (e.g., U.S. Army Corps of Engineers and U.S. Army Intelligence and Security Command).
• Communicate procedure guidance to all DoD organizations utilizing RHRP services.
• Will expire effective 12 months from the date of issue and be converted to a DHA-Procedural Instruction.
- Identification #: 19-003
- Date: 3/8/2019
- Type: DHA Interim Procedures Memorandum
- Topics:
Health Readiness
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z).
This DHA-PI applies to:
a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”).
b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.
- Identification #: DHA PI 6200.05
- Date: 5/2/2018
- Type: DHA Procedural Instruction
- Topics:
Health Readiness
Policy
This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.
Policy
This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.
Policy
Clarification of the Requirement for Continuation of Semi-Annual Reporting of
Results of Embedded Fragment Analyses
Policy
Guidance as of 17 OCT 2014 from the Department of Defese (AFHSC)for Detecting and Reporting DoD Cases of Ebola Virus Disease Infection
Showing results 1 - 15
Page 1 of 3